These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34610960)

  • 1. DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.
    Ge Y; Fan X; Huang X; Weygant N; Xiao Z; Yan R; Liu H; Liu J; An G; Yao J
    Mol Cancer Res; 2021 Dec; 19(12):1980-1991. PubMed ID: 34610960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPB41L5 promotes EMT through the ERK/p38 MAPK signaling pathway in esophageal squamous cell carcinoma.
    Bao S; Ji Z; Shi M; Liu X
    Pathol Res Pract; 2021 Dec; 228():153682. PubMed ID: 34784520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LOC146880 promotes esophageal squamous cell carcinoma progression via miR-328-5p/FSCN1/MAPK axis.
    Tang J; Xu H; Liu Q; Zheng J; Pan C; Li Z; Wen W; Wang J; Zhu Q; Wang Z; Chen L
    Aging (Albany NY); 2021 May; 13(10):14198-14218. PubMed ID: 34016787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non‑coding RNA BANCR mediates esophageal squamous cell carcinoma progression by regulating the IGF1R/Raf/MEK/ERK pathway via miR‑338‑3p.
    Song W; Wang K; Yang X; Dai W; Fan Z
    Int J Mol Med; 2020 Oct; 46(4):1377-1388. PubMed ID: 32945416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 7. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUPR1 induces autophagy and promotes the progression of Esophageal squamous cell carcinoma via the MAPK-mTOR pathway.
    Ren S; Chen Y; Wang Q; Song L; Xin Z; Shi M; Liu X
    Pathol Res Pract; 2024 May; 257():155323. PubMed ID: 38653091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
    Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
    Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
    Liu B; Li X; Li C; Xu R; Sun X
    Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
    Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
    Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
    Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
    J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma.
    Xu F; Liu Z; Liu R; Lu C; Wang L; Mao W; Zhu Q; Shou H; Zhang K; Li Y; Chu Y; Gu J; Ge D
    Cell Commun Signal; 2020 Feb; 18(1):17. PubMed ID: 32014008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KISS-1, Mediated by Promoter Methylation, Suppresses Esophageal Squamous Cell Carcinoma Metastasis via MMP2/9/MAPK Axis.
    Duan H; Ding X; Luo H
    Dig Dis Sci; 2022 Oct; 67(10):4780-4796. PubMed ID: 34993679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma.
    Tian J; Lu Z; Niu S; Zhang S; Ying P; Wang L; Zhang M; Cai Y; Dong T; Zhu Y; Zhong R; Wang Z; Chang J; Miao X
    Clin Transl Med; 2021 Jun; 11(6):e485. PubMed ID: 34185429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.